Immunomolecular Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Immunomolecular Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes (NCT04625595) | Immunomolecular Therapeutics, Inc. | 2020-11-09 |
Track Immunomolecular Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.